Get access

Can objective endpoints be manipulated in unmasked trials?

Authors


  • This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Vance W. Berger, Biometry Research Group, National Cancer Institute, Executive Plaza North, Suite 3131, 6130 Executive Boulevard, MSC 7354, Bethesda, MD 20892-7354, U.S.A.

E-mail: vb78c@nih.gov

No abstract is available for this article.

Ancillary